Literature DB >> 93598

Studies of metallobleomycins by electronic spectroscopy, electron spin resonance spectroscopy, and potentiometric titration.

Y Sugiura, K Ishizu, K Miyoshi.   

Abstract

The 1:1 bleomycin-A2-Cu(II) complex shows an absorption maximum at 595 nm (epsilon 120), circular dichroism extrema at 555 nm (delta epsilon + 1.21) and 665 nm (-0.61), and electron spin resonance (ESR) signal with g = 2.211, g = 2.055, and A = 178 x 10(-4) cm-1. The formation constant (log K = 12.630) and deprotonation constant (PKc = 3.585) of the 1:1 bleomycin-Cu(II) complex were determined by computer analysis of potentiometric data. The results of potentiometric titration also indicate that the stability of bleomycin-metal complexes is in the order Fe(II) less than Co(II) less than Ni(II) less than Cu(II) greater than Zn(II) and that these divalent metal complexes have a similar coordination environment. The bleomycin-Cu(II) complex has substantially a square-pyramidal configuration in which the secondary amine nitrogen, pyrimidine(N-1) ring nitrogen, deprotonated peptide nitrogen of histidine residue, and histidine imidazole(N-1) nitrogen coordinate to Cu(II) as planar ligand donors, and the alpha-amino nitrogen as axial donor. The specific Cu(II)-binding site of bleomycin has been compared with that of human serum albumin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93598     DOI: 10.7164/antibiotics.32.453

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  The DNA sequence specificity of bleomycin cleavage in telomeric sequences in human cells.

Authors:  Hanh T Q Nguyen; Vincent Murray
Journal:  J Biol Inorg Chem       Date:  2012-09-09       Impact factor: 3.358

2.  Structural study of copper(I)-bleomycin.

Authors:  Teresa E Lehmann
Journal:  J Biol Inorg Chem       Date:  2004-03-10       Impact factor: 3.358

3.  ESR of copper and iron complexes with antitumor and cytotoxic properties.

Authors:  W E Antholine; B Kalyanaraman; D H Petering
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

Review 4.  The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA.

Authors:  Vincent Murray; Jon K Chen; Long H Chung
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

5.  Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy.

Authors:  Kavita Gaur; Alexandra M Vázquez-Salgado; Geraldo Duran-Camacho; Irivette Dominguez-Martinez; Josué A Benjamín-Rivera; Lauren Fernández-Vega; Lesly Carmona Sarabia; Angelys Cruz García; Felipe Pérez-Deliz; José A Méndez Román; Melissa Vega-Cartagena; Sergio A Loza-Rosas; Xaymara Rodriguez Acevedo; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2018-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.